| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Chemotherapeutic Prevention Studies of Prostate Cancer
|
DJAVAN, BOB
|
|
2004
|
171 |
2S |
p. S10-S14
5 p.
|
artikel
|
| 2 |
CME Assessment Test Questions
|
|
|
2004
|
171 |
2S |
p. S77-S78
2 p.
|
artikel
|
| 3 |
CME Test Response and Evaluation Form
|
|
|
2004
|
171 |
2S |
p. S79-S80
2 p.
|
artikel
|
| 4 |
Conference Participants
|
|
|
2004
|
171 |
2S |
p. S2-
1 p.
|
artikel
|
| 5 |
Dietary Fat and Prostate Cancer
|
FLESHNER, NEIL
|
|
2004
|
171 |
2S |
p. S19-S24
6 p.
|
artikel
|
| 6 |
DISCUSSION
|
|
|
2004
|
171 |
2S |
p. S13-S14
2 p.
|
artikel
|
| 7 |
DISCUSSION
|
|
|
2004
|
171 |
2S |
p. S9-
1 p.
|
artikel
|
| 8 |
Epidemiology of Inflammation and Prostate Cancer
|
PLATZ, ELIZABETH A.
|
|
2004
|
171 |
2S |
p. S36-S40
5 p.
|
artikel
|
| 9 |
First International Conference on Chemoprevention of Prostate Cancer
|
THOMPSON, IAN M.
|
|
2004
|
171 |
2S |
p. S3-S4
2 p.
|
artikel
|
| 10 |
Genetic Variations in the Vitamin D Receptor, Androgen Receptor and Enzymes that Regulate Androgen Metabolism
|
PRICE, DOUGLAS K.
|
|
2004
|
171 |
2S |
p. S45-S49
5 p.
|
artikel
|
| 11 |
Inflammation as a Target for Prostate Cancer Chemoprevention: Pathological and Laboratory Rationale
|
LUCIA, M. SCOTT
|
|
2004
|
171 |
2S |
p. S30-S35
6 p.
|
artikel
|
| 12 |
Molecular Epidemiology of Androgen-Metabolic Loci in Prostate Cancer: Predisposition and Progression
|
MAKRIDAKIS, NICK M.
|
|
2004
|
171 |
2S |
p. S25-S29
5 p.
|
artikel
|
| 13 |
Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Selective Inhibitors for Prostate Cancer Chemoprevention
|
BASLER, JOSEPH W.
|
|
2004
|
171 |
2S |
p. S59-S63
5 p.
|
artikel
|
| 14 |
Novel Therapeutic Molecular Targets for Prostate Cancer: The mTor Signaling Pathway and Epidermal Growth Factor Receptor
|
TOLCHER, ANTHONY W.
|
|
2004
|
171 |
2S |
p. S41-S44
4 p.
|
artikel
|
| 15 |
PROCEEDINGS OF THE FIRST INTERNATIONAL CONFERENCE ON CHEMOPREVENTION OF PROSTATE CANCER
|
|
|
2004
|
171 |
2S |
p. S76-
1 p.
|
artikel
|
| 16 |
Prostate Cancer Chemoprevention Agent Development: The National Cancer Institute, Division of Cancer Prevention Portfolio
|
PARNES, HOWARD L.
|
|
2004
|
171 |
2S |
p. S68-S75
8 p.
|
artikel
|
| 17 |
Prostate Cancer Chemoprevention: An Overview of United States Trials
|
BARQAWI, ALBAHA
|
|
2004
|
171 |
2S |
p. S5-S9
5 p.
|
artikel
|
| 18 |
Selenium: Epidemiology and Basic Science
|
KLEIN, ERIC A.
|
|
2004
|
171 |
2S |
p. S50-S53
4 p.
|
artikel
|
| 19 |
Sponsorship and CME Credit
|
|
|
2004
|
171 |
2S |
p. S1-
1 p.
|
artikel
|
| 20 |
Statistical Design Issues and Other Practical Considerations for Conducting Phase III Prostate Cancer Prevention Trials
|
TANGEN, CATHERINE M.
|
|
2004
|
171 |
2S |
p. S64-S67
4 p.
|
artikel
|
| 21 |
The Prostate Cancer Prevention Trial: Current Status
|
HIGGINS, BETSY
|
|
2004
|
171 |
2S |
p. S15-S18
4 p.
|
artikel
|
| 22 |
Vitamin A, Retinoids and Carotenoids as Chemopreventive Agents for Prostate Cancer
|
KRISTAL, ALAN R.
|
|
2004
|
171 |
2S |
p. S54-S58
5 p.
|
artikel
|
Tijdschrift beschrijving